African trypanosomiasis
- B56 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
- The 2024 edition of ICD-10-CM B56 became effective on October 1, 2023.
- This is the American ICD-10-CM version of B56 – other international versions of ICD-10 B56 may differ.
The following code(s) above B56 contain annotation back-references
that may be applicable to B56:
Clinical Information
- A disease endemic among people and animals in central africa. It is caused by various species of trypanosomes, particularly t. Gambiense and t. Rhodesiense. Its second host is the tsetse fly. Involvement of the central nervous system produces “african sleeping sickness.” nagana is a rapidly fatal trypanosomiasis of horses and other animals.
- A parasitic disorder caused by protozoa of the trypanosoma brucei species. It is transmitted by flies and is endemic in various regions of sub-saharan africa. Signs and symptoms include fever, joint pain, headache, and significant swelling of the lymph nodes. If left untreated, the parasitic infection causes anemia, heart, kidney, and endocrine failure, and neurologic damage. Subsequently patients develop confusion, disruption of the sleep cycle, and mental deterioration. The infection may lead to coma and death.
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change
Code annotations containing back-references to B56: